| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | Ig_I-set | 1.77e-04 | 190 | 81 | 6 | IPR013098 | |
| Domain | I-set | 1.77e-04 | 190 | 81 | 6 | PF07679 | |
| Domain | DZF | 1.84e-04 | 5 | 81 | 2 | SM00572 | |
| Domain | DZF_dom | 1.84e-04 | 5 | 81 | 2 | IPR006561 | |
| Domain | DZF | 1.84e-04 | 5 | 81 | 2 | PF07528 | |
| Domain | DZF | 1.84e-04 | 5 | 81 | 2 | PS51703 | |
| Domain | FN3 | 2.27e-04 | 199 | 81 | 6 | PS50853 | |
| Domain | Ig-like_fold | IL13RA1 SIGIRR SPEG OBSCN OBSL1 FNDC4 LSAMP LRRC4B KDR IL2RB EXOSC2 | 2.27e-04 | 706 | 81 | 11 | IPR013783 |
| Domain | FN3_dom | 2.95e-04 | 209 | 81 | 6 | IPR003961 | |
| Domain | IGc2 | 5.50e-04 | 235 | 81 | 6 | SM00408 | |
| Domain | Ig_sub2 | 5.50e-04 | 235 | 81 | 6 | IPR003598 | |
| Domain | - | IL13RA1 SIGIRR SPEG OBSCN OBSL1 FNDC4 LSAMP LRRC4B KDR IL2RB | 5.75e-04 | 663 | 81 | 10 | 2.60.40.10 |
| Domain | FN3 | 1.26e-03 | 185 | 81 | 5 | SM00060 | |
| Domain | fn3 | 5.41e-03 | 162 | 81 | 4 | PF00041 | |
| Domain | IG_LIKE | 5.42e-03 | 491 | 81 | 7 | PS50835 | |
| Domain | Ig-like_dom | 6.16e-03 | 503 | 81 | 7 | IPR007110 | |
| Pubmed | 2.80e-06 | 162 | 84 | 6 | 25826454 | ||
| Pubmed | Plk1 regulates liver tumor cell death by phosphorylation of TAp63. | 5.76e-06 | 2 | 84 | 2 | 19668228 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 18199543 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 19148550 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 24099991 | ||
| Pubmed | ATDC mediates a TP63-regulated basal cancer invasive program. | 5.76e-06 | 2 | 84 | 2 | 30643195 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 33908161 | ||
| Pubmed | Targeting the Stromal Pro-Tumoral Hyaluronan-CD44 Pathway in Pancreatic Cancer. | 5.76e-06 | 2 | 84 | 2 | 33921242 | |
| Pubmed | Phospho-ΔNp63α/SREBF1 protein interactions: bridging cell metabolism and cisplatin chemoresistance. | 5.76e-06 | 2 | 84 | 2 | 22951905 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 17121863 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 18769144 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 15185077 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 19265164 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 35055060 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 20170163 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 15280449 | ||
| Pubmed | Tel2 structure and function in the Hsp90-dependent maturation of mTOR and ATR complexes. | 1.28e-05 | 19 | 84 | 3 | 20801936 | |
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 25325984 | ||
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 21935375 | ||
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 18344416 | ||
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 33450211 | ||
| Pubmed | Prognostic significance of CA 125, CD44, and epithelial membrane antigen in renal cell carcinoma. | 1.73e-05 | 3 | 84 | 2 | 12893366 | |
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 11279005 | ||
| Pubmed | ATM/Wip1 activities at chromatin control Plk1 re-activation to determine G2 checkpoint duration. | 1.73e-05 | 3 | 84 | 2 | 28607002 | |
| Pubmed | ΔNp63 drives metastasis in breast cancer cells via PI3K/CD44v6 axis. | 1.73e-05 | 3 | 84 | 2 | 27494839 | |
| Pubmed | Structural insight into M-band assembly and mechanics from the titin-obscurin-like-1 complex. | 1.73e-05 | 3 | 84 | 2 | 20133654 | |
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 19061978 | ||
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 32993587 | ||
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 11574540 | ||
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 9435229 | ||
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 27989621 | ||
| Pubmed | SPATA18, a spermatogenesis-associated gene, is a novel transcriptional target of p53 and p63. | 1.73e-05 | 3 | 84 | 2 | 21300779 | |
| Pubmed | Mitotic DNA damage response: Polo-like kinase-1 is dephosphorylated through ATM-Chk1 pathway. | 1.73e-05 | 3 | 84 | 2 | 20581453 | |
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 31098411 | ||
| Pubmed | Molecular basis of the head-to-tail assembly of giant muscle proteins obscurin-like 1 and titin. | 1.73e-05 | 3 | 84 | 2 | 20489725 | |
| Pubmed | A CD44v6 peptide reveals a role of CD44 in VEGFR-2 signaling and angiogenesis. | 1.73e-05 | 3 | 84 | 2 | 19773544 | |
| Pubmed | 3.45e-05 | 4 | 84 | 2 | 34838521 | ||
| Pubmed | 3.45e-05 | 4 | 84 | 2 | 23071680 | ||
| Pubmed | 3.45e-05 | 4 | 84 | 2 | 23129777 | ||
| Pubmed | 3.45e-05 | 4 | 84 | 2 | 17242158 | ||
| Pubmed | 3.45e-05 | 4 | 84 | 2 | 20048340 | ||
| Pubmed | 3.45e-05 | 4 | 84 | 2 | 11901158 | ||
| Pubmed | 3.45e-05 | 4 | 84 | 2 | 24489092 | ||
| Pubmed | 3.45e-05 | 4 | 84 | 2 | 16520463 | ||
| Pubmed | Hyaluronan synthase induction and hyaluronan accumulation in mouse epidermis following skin injury. | 3.45e-05 | 4 | 84 | 2 | 15854028 | |
| Pubmed | Chk2 activation and phosphorylation-dependent oligomerization. | 5.74e-05 | 5 | 84 | 2 | 12024051 | |
| Pubmed | WAC Promotes Polo-like Kinase 1 Activation for Timely Mitotic Entry. | 5.74e-05 | 5 | 84 | 2 | 30021153 | |
| Pubmed | 5.74e-05 | 5 | 84 | 2 | 18609713 | ||
| Pubmed | 5.74e-05 | 5 | 84 | 2 | 20179233 | ||
| Pubmed | A role for E1B-AP5 in ATR signaling pathways during adenovirus infection. | 5.74e-05 | 5 | 84 | 2 | 18480432 | |
| Pubmed | 5.74e-05 | 5 | 84 | 2 | 18662989 | ||
| Pubmed | VEGF-C is required for intestinal lymphatic vessel maintenance and lipid absorption. | 5.74e-05 | 5 | 84 | 2 | 26459520 | |
| Pubmed | Polo-like kinase 1 and Chk2 interact and co-localize to centrosomes and the midbody. | 5.74e-05 | 5 | 84 | 2 | 12493754 | |
| Pubmed | 5.74e-05 | 5 | 84 | 2 | 12242661 | ||
| Pubmed | Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro. | 5.74e-05 | 5 | 84 | 2 | 10973490 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | 7.25e-05 | 736 | 84 | 9 | 29676528 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 8.40e-05 | 430 | 84 | 7 | 35044719 | |
| Pubmed | The Schlemm's canal is a VEGF-C/VEGFR-3-responsive lymphatic-like vessel. | 8.59e-05 | 6 | 84 | 2 | 25061878 | |
| Pubmed | Reversal of female infertility by Chk2 ablation reveals the oocyte DNA damage checkpoint pathway. | 8.59e-05 | 6 | 84 | 2 | 24482479 | |
| Pubmed | Ranking novel cancer driving synthetic lethal gene pairs using TCGA data. | 8.59e-05 | 6 | 84 | 2 | 27438146 | |
| Pubmed | 8.59e-05 | 6 | 84 | 2 | 19577615 | ||
| Pubmed | Minichromosome maintenance proteins are direct targets of the ATM and ATR checkpoint kinases. | 8.59e-05 | 6 | 84 | 2 | 15210935 | |
| Pubmed | 8.59e-05 | 6 | 84 | 2 | 18583959 | ||
| Pubmed | 1.09e-04 | 777 | 84 | 9 | 35844135 | ||
| Pubmed | 1.16e-04 | 453 | 84 | 7 | 29656893 | ||
| Pubmed | DNA repair gene polymorphisms and risk of pancreatic cancer. | 1.20e-04 | 7 | 84 | 2 | 19147782 | |
| Pubmed | Diagnostic and prognostic tissuemarkers in clear cell and papillary renal cell carcinoma. | 1.20e-04 | 7 | 84 | 2 | 21694464 | |
| Pubmed | 1.20e-04 | 7 | 84 | 2 | 15887267 | ||
| Pubmed | 1.20e-04 | 7 | 84 | 2 | 34336823 | ||
| Pubmed | p53 and TAp63 participate in the recombination-dependent pachytene arrest in mouse spermatocytes. | 1.20e-04 | 7 | 84 | 2 | 28617799 | |
| Pubmed | 1.20e-04 | 7 | 84 | 2 | 17171639 | ||
| Pubmed | Transgenic mouse models in angiogenesis and cardiovascular disease. | 1.20e-04 | 7 | 84 | 2 | 10685072 | |
| Pubmed | Systematic identification of NF90 target RNAs by iCLIP analysis. | 1.36e-04 | 41 | 84 | 3 | 35013429 | |
| Pubmed | 1.60e-04 | 8 | 84 | 2 | 17324121 | ||
| Pubmed | 1.60e-04 | 8 | 84 | 2 | 20810650 | ||
| Pubmed | 1.95e-04 | 493 | 84 | 7 | 15368895 | ||
| Pubmed | 2.02e-04 | 496 | 84 | 7 | 31343991 | ||
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | 2.05e-04 | 497 | 84 | 7 | 36774506 | |
| Pubmed | 2.05e-04 | 9 | 84 | 2 | 15601856 | ||
| Pubmed | 2.05e-04 | 9 | 84 | 2 | 22662233 | ||
| Pubmed | Dual functions of ASCIZ in the DNA base damage response and pulmonary organogenesis. | 2.05e-04 | 9 | 84 | 2 | 20975950 | |
| Pubmed | 2.05e-04 | 9 | 84 | 2 | 24657168 | ||
| Pubmed | Proteolytic activation defines distinct lymphangiogenic mechanisms for VEGFC and VEGFD. | 2.05e-04 | 9 | 84 | 2 | 27159393 | |
| Pubmed | 2.19e-04 | 1049 | 84 | 10 | 27880917 | ||
| Pubmed | PASK CHCHD3 NAA35 IARS2 PTPN14 ILF3 RPAP1 CLCN7 RRP12 OBSL1 ATM ABHD12 | 2.34e-04 | 1487 | 84 | 12 | 33957083 | |
| Pubmed | Genetic control of leucocyte--endothelial cell interaction in collagen-induced arthritis. | 2.56e-04 | 10 | 84 | 2 | 20223839 | |
| Pubmed | 2.57e-04 | 686 | 84 | 8 | 28380382 | ||
| Pubmed | TRIM65 regulates microRNA activity by ubiquitination of TNRC6. | 2.58e-04 | 364 | 84 | 6 | 24778252 | |
| Pubmed | CRL4 complex regulates mammalian oocyte survival and reprogramming by activation of TET proteins. | 2.92e-04 | 53 | 84 | 3 | 24357321 | |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | 3.05e-04 | 704 | 84 | 8 | 29955894 | |
| Pubmed | Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma. | 3.11e-04 | 377 | 84 | 6 | 38117590 | |
| Pubmed | Tti1 and Tel2 are critical factors in mammalian target of rapamycin complex assembly. | 3.13e-04 | 11 | 84 | 2 | 20427287 | |
| Pubmed | Conserved modes of recruitment of ATM, ATR and DNA-PKcs to sites of DNA damage. | 3.13e-04 | 11 | 84 | 2 | 15758953 | |
| Pubmed | 3.13e-04 | 11 | 84 | 2 | 39349721 | ||
| Pubmed | 3.29e-04 | 381 | 84 | 6 | 18676680 | ||
| Pubmed | Polymorphisms in innate immunity genes and lung cancer risk in Xuanwei, China. | 3.34e-04 | 382 | 84 | 6 | 19170196 | |
| Pubmed | IL13RA1 CHCHD3 NAA35 GTPBP2 ILF3 PPME1 PABPC4L PLK1 BIRC6 RAD54L WAC | 3.46e-04 | 1327 | 84 | 11 | 32694731 | |
| Pubmed | 3.72e-04 | 390 | 84 | 6 | 17643375 | ||
| Pubmed | Identification of potential bladder progenitor cells in the trigone. | 3.75e-04 | 12 | 84 | 2 | 24992712 | |
| Pubmed | Final stages of cytokinesis and midbody ring formation are controlled by BRUCE. | 3.75e-04 | 12 | 84 | 2 | 18329369 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 6.59e-06 | 161 | 52 | 6 | 593 | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_E|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.20e-05 | 157 | 84 | 5 | 0362c04b7b0b5017964b3a73ee678ae53e7238d7 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Lymphocytic-Proliferating_NK|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.81e-05 | 171 | 84 | 5 | 1eebd7138c3b20ddc1104f21615f9df0e776bbe6 | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_E|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.97e-05 | 174 | 84 | 5 | a1f745962a104c6f4b86b7e482da8755384c773a | |
| ToppCell | facs-Lung-24m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.32e-05 | 180 | 84 | 5 | baa5825e6ce23a98d9c21d024a4b0ab8ba353d0c | |
| ToppCell | facs-Lung-24m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.32e-05 | 180 | 84 | 5 | 2d608b9394d28d19cfc85c6ac94003d5177c8a92 | |
| ToppCell | facs-Lung-24m-Endothelial-arterial_endothelial|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.32e-05 | 180 | 84 | 5 | 0f9b27054358c4737eed06c8ea01987cccc3cb55 | |
| ToppCell | droplet-Lung-21m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.64e-05 | 185 | 84 | 5 | 1b990e3089772be2b38c6d7ea0d1bf22461ae3ea | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-basal_cell_of_epidermis|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.78e-05 | 187 | 84 | 5 | 9c1013720c248ef201d010806b6e7ad24205e8ee | |
| ToppCell | facs-Kidney-nan-24m-Lymphocytic|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.78e-05 | 187 | 84 | 5 | e4cb79c7aa29e8c99d5a3a209d2f9a03c2ba9bb7 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_T/NK-T_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.00e-05 | 190 | 84 | 5 | 07ea0578ca0561077557203ae660530f53fc4067 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_T/NK-T_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.00e-05 | 190 | 84 | 5 | 5b4b3eed7aa798bb7e3c5e968c8dc4144e377a5f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_T/NK|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.08e-05 | 191 | 84 | 5 | 96a7179a845d3daa046ed71fa45c51255f130a7f | |
| ToppCell | COVID-19-kidney-T-cells-1|kidney / Disease (COVID-19 only), tissue and cell type | 3.57e-05 | 197 | 84 | 5 | 9bb7faf4ef63cca4d06c60e6c05a9616fdb6b98e | |
| ToppCell | LPS_anti-TNF-Epithelial_airway-airway_epithelial-Airway-Club|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.65e-05 | 198 | 84 | 5 | 6712216c5a7fd86b68fd45b0ff7794975f19774e | |
| ToppCell | LPS_anti-TNF-Epithelial_airway-airway_epithelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.74e-05 | 199 | 84 | 5 | 60919c2af31d39a2d36d7bc432e43dab2a4e05fb | |
| ToppCell | LPS_anti-TNF-Epithelial_airway|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.74e-05 | 199 | 84 | 5 | 6aca164bbbb961f34b1e6f1857f91ade5c059405 | |
| ToppCell | LPS_IL1RA-Epithelial_airway-airway_epithelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.83e-05 | 200 | 84 | 5 | cf191104484bfb2b9f87de416b9453135f8833c1 | |
| ToppCell | LPS_IL1RA-Epithelial_airway|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.83e-05 | 200 | 84 | 5 | a5ae33dd4dc1ff6e1a1eec22c4d523d5ab657607 | |
| ToppCell | (01)_IL1RL1+|World / shred by cell type by condition | 3.83e-05 | 200 | 84 | 5 | 501420901bf3ec1b050e0d14596a9f9f3fdfc928 | |
| Disease | urinary bladder cancer (is_marker_for) | 1.32e-05 | 107 | 83 | 5 | DOID:11054 (is_marker_for) | |
| Disease | Juvenile pauciarticular chronic arthritis | 1.63e-04 | 7 | 83 | 2 | C2931171 | |
| Disease | Pancreatic Neoplasm | 1.86e-04 | 100 | 83 | 4 | C0030297 | |
| Disease | Malignant neoplasm of pancreas | 2.01e-04 | 102 | 83 | 4 | C0346647 | |
| Disease | Malignant neoplasm of breast | NLRP14 LIPE PTPN14 CEP85L SPATA18 OBSCN DIP2C KDR ATM RAD54L STAT4 | 2.07e-04 | 1074 | 83 | 11 | C0006142 |
| Disease | breast carcinoma (is_marker_for) | 8.64e-04 | 66 | 83 | 3 | DOID:3459 (is_marker_for) | |
| Disease | Low Grade Lymphoma (neoplasm) | 1.59e-03 | 21 | 83 | 2 | C0079747 | |
| Disease | Lymphoma, Intermediate-Grade | 1.59e-03 | 21 | 83 | 2 | C0079741 | |
| Disease | High Grade Lymphoma (neoplasm) | 1.59e-03 | 21 | 83 | 2 | C0079740 | |
| Disease | Diffuse Mixed-Cell Lymphoma | 1.59e-03 | 21 | 83 | 2 | C0079757 | |
| Disease | Lymphoma, Undifferentiated | 1.59e-03 | 21 | 83 | 2 | C0024306 | |
| Disease | Reticulosarcoma | 1.59e-03 | 21 | 83 | 2 | C0024302 | |
| Disease | Lymphoma, Mixed-Cell | 1.59e-03 | 21 | 83 | 2 | C0024304 | |
| Disease | BREAST CANCER | 1.59e-03 | 21 | 83 | 2 | 114480 | |
| Disease | Lymphoma, Diffuse | 1.59e-03 | 21 | 83 | 2 | C3714542 | |
| Disease | Lymphoma, Non-Hodgkin, Familial | 1.74e-03 | 22 | 83 | 2 | C4721532 | |
| Disease | transitional cell carcinoma (is_implicated_in) | 1.74e-03 | 22 | 83 | 2 | DOID:2671 (is_implicated_in) | |
| Disease | Lymphoma, Small Noncleaved-Cell | 1.74e-03 | 22 | 83 | 2 | C0079770 | |
| Disease | creatinine measurement | 1.92e-03 | 995 | 83 | 9 | EFO_0004518 | |
| Disease | glioblastoma (is_implicated_in) | 2.07e-03 | 24 | 83 | 2 | DOID:3068 (is_implicated_in) | |
| Disease | Left ventricular mass to end-diastolic volume ratio | 2.25e-03 | 25 | 83 | 2 | EFO_0010556 | |
| Disease | Hereditary Nonpolyposis Colorectal Neoplasms | 2.43e-03 | 26 | 83 | 2 | C0009405 | |
| Disease | Malignant tumor of breast | 2.62e-03 | 27 | 83 | 2 | cv:C0006142 | |
| Disease | Breast neoplasm | 2.62e-03 | 27 | 83 | 2 | cv:C1458155 | |
| Disease | Familial cancer of breast | 2.62e-03 | 27 | 83 | 2 | cv:C0346153 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| IEARRVCVTFRELSA | 261 | Q9NXW9 | |
| IVRRLGVQECILLVT | 586 | Q6ZSZ5 | |
| RGCDLLQEVSVTIRR | 1291 | Q9NR09 | |
| ILRREVQDAVKCRVV | 1186 | O14514 | |
| SITCKARIRRENIVV | 6 | Q5VT40 | |
| CAKTTVERTVRQLER | 321 | Q9BX10 | |
| VIAELRLRQCADTRV | 191 | Q9H221 | |
| CLRTTEETRRNVTIP | 11 | Q5H913 | |
| CIVRQALEREDSIRT | 516 | Q9ULJ7 | |
| LVRRAVLRLTVTVQD | 246 | Q8N7S6 | |
| SIVNRCLIRRTSDIL | 386 | Q92698 | |
| TAAIISRVQCRIVAL | 96 | Q9Y570 | |
| LICQRDTILSERTRD | 301 | Q8N6L0 | |
| VATNLVRRLCERETP | 251 | Q8N2K0 | |
| RLTVRERTVAVLSEL | 1711 | O75147 | |
| VITCLICGVLVTTRR | 14466 | Q8WXI7 | |
| RQERRLCCVVVLEPV | 221 | Q96RG2 | |
| LRVVRTTFERCELVR | 146 | A8MXD5 | |
| LRRCIDKAETVQRII | 321 | Q8TC71 | |
| TVCIRDSQSILVRTR | 1271 | Q5HYC2 | |
| VELTRELQDSIRRCL | 6 | Q8ND23 | |
| TCLRRREKVGVIVDV | 636 | P51798 | |
| FCETVKIIIRDQRSV | 181 | O95237 | |
| VRRCITRTSQVLVIL | 151 | Q86UY5 | |
| EFDICLTSVQKRVIR | 51 | Q8N0Y7 | |
| QVLIRILISRCETDL | 291 | O76027 | |
| REVISRLRNCIISLV | 231 | Q13868 | |
| IRCRIQQRNITTVVE | 116 | Q8TAG9 | |
| ETRRSIEVPLNERIC | 81 | P78552 | |
| QLTRAILRERICSEE | 101 | Q9NX63 | |
| KVRVEAVGCTRRLVV | 1671 | Q5VST9 | |
| ELRTLCRRLQITTRE | 671 | Q8N573 | |
| ERVIDAVRFTLRQTI | 636 | Q9H3D4 | |
| EDRTEAANRIICTIR | 2596 | Q13315 | |
| VVSCVVIERVGRRVL | 326 | Q9BYW1 | |
| IVRGLVRIRCVQEVE | 336 | Q8NB78 | |
| ALILAVCIAVNSRRR | 661 | P16070 | |
| RVIREVNTTTRACAL | 91 | Q9H6D8 | |
| CVIVIRVLRDLCTRV | 226 | Q12906 | |
| VDIVTLRVLCREGVR | 101 | P14784 | |
| DLSRVRTCVVVAEER | 1256 | Q9Y2E4 | |
| RTCVVVAEERPRIAL | 1261 | Q9Y2E4 | |
| VCQLRRDIDELRTTI | 776 | Q5SZL2 | |
| RSRDILTDVVIVVSR | 26 | P41182 | |
| VEALVRTRRCVCVAQ | 196 | Q92839 | |
| EVLVVLRSISEQCRR | 531 | Q5T6L9 | |
| DQQRRTVRCLRDTVL | 711 | Q8WXE1 | |
| CITIIVGSIRRDRQA | 51 | Q3B7T3 | |
| IVRSLRQDRVAFCVT | 3791 | Q9P225 | |
| QASRVICTRRDLAEV | 66 | Q9NT99 | |
| TRQAAELCVERIRLV | 1036 | Q05469 | |
| VLSIRICRDQVTRRS | 36 | P0CB38 | |
| EVASVVVQLLSIRRC | 271 | O14654 | |
| SSVCRDLDVVRRIIC | 181 | Q9BV86 | |
| ITVRQGDTAILRCVV | 41 | Q13449 | |
| RRNLASITRIVEVDV | 516 | Q9Y6U3 | |
| RLQTILRTVEGCIVA | 501 | Q96MK3 | |
| VLEGRLRCTLDQVIR | 126 | Q15678 | |
| ELRTQVRELRSIIET | 611 | Q96B97 | |
| VNLSRCRRLIVVLSD | 216 | Q6IA17 | |
| LVRVCEIQATLREQR | 611 | Q9BTA9 | |
| RRSCQTALVEILDVI | 816 | Q9NSE4 | |
| DLRVTVCQALRTLIT | 656 | Q5JTH9 | |
| RVVDLCRNVKERITR | 536 | O00116 | |
| AGCVEERVSLIRRSV | 471 | Q13705 | |
| QRTLSRVELKRLCEI | 886 | Q7Z460 | |
| RLIDRIKTVCEVVNL | 331 | Q5VZE5 | |
| RRRGLVIVTELCTEE | 1666 | Q15772 | |
| ESLCRVINICERVVR | 766 | Q9H5L6 | |
| LRDQGRIVCAERTVL | 726 | Q14159 | |
| VAVVISNCLREERRI | 101 | Q14765 | |
| VIRTLRSQEACLEAV | 451 | Q86SX3 | |
| TRVLECPRLIETIVR | 581 | Q9BWH6 | |
| RVARRDICIAFQETL | 226 | Q8TE23 | |
| SICQVEIEALAKRRR | 781 | Q9Y2K6 | |
| FVNEVRRCESLERIL | 51 | Q9HBG4 | |
| SCVIIIRILRDLCQR | 921 | Q96KR1 | |
| KRHCVVRQLTVLERV | 651 | P35968 | |
| SIIRRSIQIPEEDRC | 201 | O43915 | |
| LSIVRTNRAEIPIEC | 126 | P21754 | |
| TLTAVILVLTRRCRT | 401 | P21754 | |
| RLKVLEREVQQCSRV | 1171 | Q8TD43 | |
| KRERLIQSVVECLTF | 66 | O43156 | |
| IRSVELQLVRVETCG | 206 | O14972 | |
| VFVVLELCRRRSLLE | 126 | P53350 | |
| QSVLSCVRSLRARIV | 506 | P23276 | |
| RCLRTIRLSVTVVFE | 626 | Q86W24 |